Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Balance Sheets

v3.7.0.1
Interim Consolidated Balance Sheets - USD ($)
May 31, 2017
Nov. 30, 2016
CURRENT    
Cash and cash equivalent $ 595,788 $ 192,826
Accounts Receivable 22,265 32,534
Inventory 232,700 7,323
Prepaid expenses and other receivables 17,872 50,037
Total Current Assets 868,625 282,720
Deferred financing costs 0 36,874
Property and Equipment 47,003 50,496
TOTAL ASSETS 915,628 370,090
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 256,984 245,911
Unsecured Convertible Debentures, net of deferred financing costs of $nil and $35,769, respectively 137,660 1,117,771
Total Current Liabilities 394,644 1,363,682
Long term secured Convertible Debentures, net of deferred financing costs of $83,329 and $nil, respectively 1,669,359 0
Derivative Financial Instruments 381,671 0
Total Liabilities 2,445,674 1,363,682
Capital Stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (2015 - nil). 0 0
Common stock, $0.001 par value 100,000,000 shares authorized (2016: 100,000,000), 56,732,099 issued and outstanding (2016: 55,104,493) 56,732 55,105
Additional Paid-In Capital 27,607,863 27,307,274
Deficiency (29,159,079) (28,298,613)
Accumulated other comprehensive loss (35,562) (57,358)
Total Stockholders' Deficiency (1,530,046) (993,592)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY $ 915,628 $ 370,090